Epinutra is a science-driven innovation company. This takes time. Biology dictates the route we take but makes for a rewarding product. Epinutra was founded in 2019 in the Netherlands on the back of 10+ years of laboratory research.

Our recent clinical trial shows that lozenges are surprisingly effective for acid reflux symptoms. Exploratory analysis of this trial reveals that our approach specifically benefits women. A serendipitous finding, yes, but women’s digestive health is a large unmet need. We are now talking to partners to see how best to build the complete case.

Meet Team Epinutra

Richard Hampson, Ph.D

Co-founder and CEO of Epinutra
  • Over 10 years experience as start-up founder.
  • Scientific group leader in biotech scale-up.
  • PhD and Postdoc research at University of London, Harvard University and King’s College London.
  • 2 granted patents, 2 ongoing applications, 16 peer-reviewed articles.

Luciana Vieira de Moraes, Ph.D

Co-founder and CSO of Epinutra

  • 20 years research experience in immunology (MSc, PhD and Postdoc).
  • Scientific lead in integrating active ingredient discovery data and pipeline design. Highly skilled at conveying scientific complexity to non-experts.
  • 1 granted patent, 2 ongoing applications, 24 peer- reviewed articles.

Sandra Slavkis, MBA

Head of Market Strategy

  • Internationally experienced manager with more than 30 years of experience in Special Foods, OTC products and FMCG.
  • Former General Director of Danone Baby Food Latin America, Spain and Portugal.
  • Passionate about growth and with a track-record of internationalisation.
  • Business Angel since 2019 and currently on the Executive Committee of WA4STEAM.

 

Will van den Tweel, Ph.D

Advisor on Commercial Development

  • Seasoned entrepreneur with strong innovation track record.
  • 35 years of experience in establishing and leading international innovation projects and JV’s (DSM, Reverdia, BioscienZ, Those Vegan Cowboys).
  • PhD in Biotechnology.